Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2004

Dec 14, 2004

34117_dirs_2004-12-14_a9eb56ea-0651-46a0-97f2-11c442c4302e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2004-10-31

Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-01-13 Common Stock G 300000 Disposed 1849310 Direct
2004-06-07 Common Stock G 100000 Disposed 1849310 Direct
2004-09-30 Common Stock G 50000 Disposed 1849310 Direct

Footnotes

F1: Amount of securities beneficially owned represents shares held and excludes shares Denis A. Krusos has the right to acquire
upon exercise of options granted pursuant to CopyTele, Inc. stock option plans

F2: Gift